Chloroquine inhibits Ca signaling in murine CD4 + thymocytes

Cellular Physiology and Biochemistry

Volumn 36, Issue 1, 2015, Pages 133-140

  Xu, Jin Chao ^a   Peng, Yong Bo ^a   Wei, Ming Yu ^a   Wu, Yi Fan ^a   Guo, Donglin ^a,b   Qin, Gangjian ^c   Ji, Guangju ^d   Shen, Jinhua ^a   Liu, Qing Hua ^a  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d INSTITUTE OF BIOPHYSICS   (China)

Author keywords

CD4 + T cells; Chloroquine; IP 3 receptor; Thapsigargin; Transient receptor potential C3 (TRPC3)

Indexed keywords

CAFFEINE; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CHLOROQUINE; FURA 2 ACETOXYMETHYL ESTER; INOSITOL 1,4,5 TRISPHOSPHATE; PYRAZOLE; THAPSIGARGIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; CALCIUM; ETHYL-1-(4-(2*3*3-TRICHLOROACRYLAMIDE)PHENYL)-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLATE; PYRAZOLE DERIVATIVE;

AIRWAY SMOOTH MUSCLE CELL; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CELL ISOLATION; DOSE RESPONSE; ENDOPLASMIC RETICULUM; EXTRACELLULAR CALCIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE; THYMUS; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM;

MURINAE;

ANIMALS; CAFFEINE; CALCIUM; CALCIUM SIGNALING; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHLOROQUINE; GENE EXPRESSION REGULATION; MALE; MICE; PYRAZOLES; THAPSIGARGIN; THYMOCYTES;

EID: 84928730190     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374058     Document Type: Article

References (37)

1. Cooper RG, Magwere T: Chloroquine: Novel uses & manifestations. Indian J Med Res 2008;127:305-316.
2. Gostner JM, Schrocksnadel S, Becker K, Jenny M, Schennach H, Uberall F, Fuchs D: Antimalarial drug chloroquine counteracts activation of indoleamine (2, 3)-dioxygenase activity in human pbmc. FEBS Open Bio 2012;2:241-245.
3. Lopez-Izquierdo A, Ponce-Balbuena D, Ferrer T, Sachse FB, Tristani-Firouzi M, Sanchez-Chapula JA: Chloroquine blocks a mutant Kir2. 1 channel responsible for short QT syndrome and normalizes repolarization properties in silico. Cell Physiol Biochem 2009;24:153-160.
4. Gilman AL, Chan KW, Mogul A, Morris C, Goldman FD, Boyer M, Cirenza E, Mazumder A, Gehan E, Cahill R, Frankel S, Schultz K: Hydroxychloroquine for the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2000;6:327-334.
5. Wozniacka A, Lesiak A, Narbutt J, McCauliffe DP, Sysa-Jedrzejowska A: Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients. Lupus 2006;15:268-275.
6. Paton NI, Goodall RL, Dunn DT, Franzen S, Collaco-Moraes Y, Gazzard BG, Williams IG, Fisher MJ, Winston A, Fox J, Orkin C, Herieka EA, Ainsworth JG, Post FA, Wansbrough-Jones M, Kelleher P: Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: A randomized controlled trial. JAMA 2012;308:353-361.
7. Lofferer O, Plasun R: [treatment of chronic lupus erythematosus with hydroxychloroquine]. Z Haut Geschlechtskr 1961;30:370-374.
8. Thome R, Lopes SC, Costa FT, Verinaud L: Chloroquine: Modes of action of an undervalued drug. Immunol Lett 2013;153:50-57.
9. Goldman FD, Gilman AL, Hollenback C, Kato RM, Premack BA, Rawlings DJ: Hydroxychloroquine inhibits calcium signals in T cells: A new mechanism to explain its immunomodulatory properties. Blood 2000;95:3460-3466.
10. Hugosson E, Bjorkman A, Troye-Blomberg M: Chloroquine enhances the number of IL-10 producing cells and the expression of b7-2 and ICAM-1 in in vitro-cultured PBMC. Scand J Immunol 2002;55:399-408.
11. Vig M, Kinet JP: Calcium signaling in immune cells. Nat Immunol 2009;10:21-27.
12. Greineisen WE, Speck M, Shimoda LM, Sung C, Phan N, Maaetoft-Udsen K, Stokes AJ, Turner H: Lipid body accumulation alters calcium signaling dynamics in immune cells. Cell Calcium 2014;56:169-180.
13. Badou A, Jha MK, Matza D, Flavell RA: Emerging roles of l-type voltage-gated and other calcium channels in T lymphocytes. Front Immunol 2013;4:243.
14. Forcic D, Mazuran R: Modulation of [Ca2+]i in freshly isolated mouse lymphocytes with in vivo priming. Immunol Lett 1999;67:23-30.
15. Aires V, Adote S, Hichami A, Moutairou K, Boustani ES, Khan NA: Modulation of intracellular calcium concentrations and T cell activation by prickly pear polyphenols. Mol Cell Biochem 2004;260:103-110.
16. Samakai E, Hooper R, Soboloff J: The critical role of stim1-dependent Ca2+ signalling during T-cell development and activation. Int J Biochem Cell Biol 2013;45:2491-2495.
17. Kim KD, Srikanth S, Yee MK, Mock DC, Lawson GW, Gwack Y: Orai1 deficiency impairs activated T cell death and enhances T cell survival. J Immunol 2011;187:3620-3630.
18. Nguyen DH, Espinoza JC, Taub DD: Cellular cholesterol enrichment impairs T cell activation and chemotaxis. Mech Ageing Dev 2004;125:641-650.
19. Schwarz EC, Kummerow C, Wenning AS, Wagner K, Sappok A, Waggershauser K, Griesemer D, Strauss B, Wolfs MJ, Quintana A, Hoth M: Calcium dependence of T cell proliferation following focal stimulation. Eur J Immunol 2007;37:2723-2733.
20. Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI: Differential activation of transcription factors induced by ca2+ response amplitude and duration. Nature 1997;386:855-858.
21. Shaw PJ, Weidinger C, Vaeth M, Luethy K, Kaech SM, Feske S: CD4+ and CD8+ T cell-dependent antiviral immunity requires STIM1 and STIM2. J Clin Invest 2014;124:4549-4563.
22. Lewis TL, Brundage KM, Brundage RA, Barnett JB: 3, 4-dichloropropionanilide (DCPA) inhibits T-cell activation by altering the intracellular calcium concentration following store depletion. Toxicol Sci 2008;103:97-107.
23. Robert V, Triffaux E, Savignac M, Pelletier L: Calcium signalling in T-lymphocytes. Biochimie 2011;93:2087-2094.
24. Rao A, Hogan PG: Calcium signaling in cells of the immune and hematopoietic systems. Immunol Rev 2009;231:5-9.
25. Zhang T, Luo XJ, Sai WB, Yu MF, Li WE, Ma YF, Chen W, Zhai K, Qin G, Guo D, Zheng YM, Wang YX, Shen JH, Ji G, Liu QH: Non-selective cation channels mediate chloroquine-induced relaxation in precontracted mouse airway smooth muscle. PloS one 2014;9:e101578.
26. Sai WB, Yu MF, Wei MY, Lu Z, Zheng YM, Wang YX, Qin G, Guo D, Ji G, Shen J, Liu QH: Bitter tastants induce relaxation of rat thoracic aorta precontracted with high K+. Clin Exp Pharmacol Physiol 2014;41:301-308.
27. Freedman BD, Liu QH, Somersan S, Kotlikoff MI, Punt JA: Receptor avidity and costimulation specify the intracellular Ca2+ signaling pattern in CD4+CD8+ thymocytes. J Exp Med 1999;190:943-952.
28. Santofimia-Castano P, Ruy DC, Fernandez-Bermejo M, Salido GM, Gonzalez A: Pharmacological dose of melatonin reduces cytosolic calcium load in response to cholecystokinin in mouse pancreatic acinar cells. Mol Cell Biochem 2014;397:75-86.
29. Ikezoe K, Furuya H, Arahata H, Nakagawa M, Tateishi T, Fujii N, Kira J: Amyloid-beta accumulation caused by chloroquine injections precedes er stress and autophagosome formation in rat skeletal muscle. Acta Neuropathol 2009;117:575-582.
30. Misra UK, Gawdi G, Pizzo SV: Chloroquine, quinine and quinidine inhibit calcium release from macrophage intracellular stores by blocking inositol 1, 4, 5-trisphosphate binding to its receptor. J Cell Biochem 1997;64:225-232.
31. Shmigol AV, Eisner DA, Wray S: Simultaneous measurements of changes in sarcoplasmic reticulum and cytosolic. J Physiol 2001;531:707-713.
32. Wenning AS, Neblung K, Strauss B, Wolfs MJ, Sappok A, Hoth M, Schwarz EC: TRP expression pattern and the functional importance of TRPC3 in primary human T-cells. Biochim Biophys Acta 2011;1813:412-423.
33. Waite JC, Vardhana S, Shaw PJ, Jang JE, McCarl CA, Cameron TO, Feske S, Dustin ML: Interference with Ca2+ release activated Ca2+ (CRAC) channel function delays T-cell arrest in vivo. Eur J Immunol 2013;43:3343-3354.
34. Schleifer H, Doleschal B, Lichtenegger M, Oppenrieder R, Derler I, Frischauf I, Glasnov TN, Kappe CO, Romanin C, Groschner K: Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca2+ entry pathways. Br J Pharmacol 2012;167:1712-1722.
35. Trebak M, Bird GS, McKay RR, Putney JW Jr: Comparison of human TRPC3 channels in receptor-activated and store-operated modes. Differential sensitivity to channel blockers suggests fundamental differences in channel composition. J Biol Chem 2002;277:21617-21623.
36. Zhang SL, Yu Y, Roos J, Kozak JA, Deerinck TJ, Ellisman MH, Stauderman KA, Cahalan MD: Stim1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature 2005;437:902-905.
37. Tan X, Sanderson MJ: Bitter tasting compounds dilate airways by inhibiting airway smooth muscle calcium oscillations and calcium sensitivity. Br J Pharmacol 2014;171:646-662.